Hydrocotyle asiatica extract | CAS:84696-21-9

We serve Hydrocotyle asiatica extract CAS:84696-21-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Hydrocotyle asiatica extract

Chemical Name:Hydrocotyle asiatica extract
CAS.NO:84696-21-9
Synonyms:Hydrocotyle asiatica extract
Hydrocotyle asiatica, ext.
Centella Asiatia
Gotu Kola Herb Extract
asiatic pennywort herb extract
 
Specification:
Appearance:Brown yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:1) Clear effect on promoting repairing skin damage, widely used for external application in skin-care products
2) Clear promotion effect on HSKa & HSFb, also with promotion effect on the formation of DNA
3) Promoting wound healing and stimulating granulation growing
4) Quenching free radical, antioxidant, and anti-aging



Contact us for information like Hydrocotyle asiatica extract chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,asiatic pennywort herb extract physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Centella Asiatia Use and application,Centella Asiatia technical grade,usp/ep/jp grade.


Related News: Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.D-Pyroglutamic acid manufacturer It has also sought to win acceptance for TCM overseas, establishing 30 overseas TCM centers in countries along the “Belt and Road Initiative,” Xi’s global infrastructure and investment program.4-(4-Methoxyphenyl)morpholine supplier This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.?6-methyl-5-nitropyridin-2-amine vendor From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances).The Philippines, the United States and Australia have expanded travel restrictions, temporarily barring noncitizens who have recently traveled to China.